Found: 19
Select item for more details and to access through your institution.
Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1762, doi. 10.1111/dom.13023
- By:
- Publication type:
- Article
A BAC/BIBAC-based physical map of chickpea, Cicer arietinum L.
- Published in:
- BMC Genomics, 2010, v. 11, p. 501, doi. 10.1186/1471-2164-11-501
- By:
- Publication type:
- Article
Non-canonical inflammasome activation targets caspase-11.
- Published in:
- Nature, 2011, v. 479, n. 7371, p. 117, doi. 10.1038/nature10558
- By:
- Publication type:
- Article
Effects of the Preservative Purite<sup>®</sup> on the Bioavailability of Brimonidine in the Aqueous Humor of Rabbits.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2004, v. 20, n. 4, p. 285, doi. 10.1089/1080768041725326
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 5, p. 1051, doi. 10.1111/bcp.12676
- By:
- Publication type:
- Article
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 3, p. 1, doi. 10.1111/cts.13730
- By:
- Publication type:
- Article
Risk assessment of drug–drug interaction potential for bintrafusp alfa with cytochrome P4503A4 substrates: A totality of evidence approach.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 12, p. 2838, doi. 10.1111/cts.13413
- By:
- Publication type:
- Article
Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1346, doi. 10.1002/cpt.3216
- By:
- Publication type:
- Article
Applying Modeling and Simulations for Rational Dose Selection of Novel Toll‐Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 297, doi. 10.1002/cpt.2606
- By:
- Publication type:
- Article
Challenges in Drug Development Posed by the COVID‐19 Pandemic: An Opportunity for Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 699, doi. 10.1002/cpt.1879
- By:
- Publication type:
- Article
Mesodermal Fgf10b cooperates with other fibroblast growth factors during induction of otic and epibranchial placodes in zebrafish.
- Published in:
- Developmental Dynamics, 2014, v. 243, n. 10, p. 1275, doi. 10.1002/dvdy.24119
- By:
- Publication type:
- Article
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics of Ibuprofen Enantiomers in Children with Cystic Fibrosis.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 8, p. 861, doi. 10.1177/009127000004000807
- By:
- Publication type:
- Article
Multi-Platform Next-Generation Sequencing of the Domestic Turkey (Meleagris gallopavo): Genome Assembly and Analysis.
- Published in:
- PLoS Biology, 2010, v. 8, n. 9, p. 1, doi. 10.1371/journal.pbio.1000475
- By:
- Publication type:
- Article
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00406-0
- By:
- Publication type:
- Article
Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug–drug interaction studies.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2075, doi. 10.1111/cts.13357
- By:
- Publication type:
- Article
Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 6, p. 2420, doi. 10.1111/cts.13108
- By:
- Publication type:
- Article
Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.
- Published in:
- 2016
- By:
- Publication type:
- journal article